{"id":5602,"date":"2021-10-13T13:41:15","date_gmt":"2021-10-13T11:41:15","guid":{"rendered":"https:\/\/www.dafrapharma.com\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/"},"modified":"2021-11-23T08:51:45","modified_gmt":"2021-11-23T07:51:45","slug":"vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021","status":"publish","type":"post","link":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/","title":{"rendered":"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE – 6 octobre, 2021"},"content":{"rendered":"

L\u2019Organisation mondiale de la Sant\u00e9 (OMS) recommande l\u2019utilisation g\u00e9n\u00e9ralis\u00e9e du vaccin antipaludique RTS,S\/AS01 (RTS,S) chez les enfants en Afrique subsaharienne et dans d’autres r\u00e9gions o\u00f9 la transmission du paludisme \u00e0 P. falciparum est mod\u00e9r\u00e9e ou forte. La recommandation est fond\u00e9e sur les r\u00e9sultats d\u2019un programme pilote en cours au Ghana, au Kenya et au Malawi qui a permis d’atteindre plus de 800\u00a0000 enfants depuis 2019.<\/p>\n

Pour plus d’information, visitez…<\/strong><\/p>\n

https:\/\/www.who.int\/fr\/news\/item\/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk?hss_channel=tw-279094659&utm_content=182637914&utm_medium=social&utm_source=twitter<\/a><\/p>\n

https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/malaria<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

L\u2019Organisation mondiale de la Sant\u00e9 (OMS) recommande l\u2019utilisation g\u00e9n\u00e9ralis\u00e9e du vaccin antipaludique RTS,S\/AS01 (RTS,S) chez les enfants en Afrique subsaharienne et dans d’autres r\u00e9gions o\u00f9 la transmission du paludisme \u00e0 P. falciparum est mod\u00e9r\u00e9e ou forte. La recommandation est fond\u00e9e sur les r\u00e9sultats d\u2019un programme pilote en cours au Ghana, au Kenya et au Malawi […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[283],"tags":[],"class_list":["post-5602","post","type-post","status-publish","format-standard","hentry","category-octobre-2021"],"yoast_head":"\nVACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE - 6 octobre, 2021 - Dafra Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE - 6 octobre, 2021 - Dafra Pharma\" \/>\n<meta property=\"og:description\" content=\"L\u2019Organisation mondiale de la Sant\u00e9 (OMS) recommande l\u2019utilisation g\u00e9n\u00e9ralis\u00e9e du vaccin antipaludique RTS,S\/AS01 (RTS,S) chez les enfants en Afrique subsaharienne et dans d’autres r\u00e9gions o\u00f9 la transmission du paludisme \u00e0 P. falciparum est mod\u00e9r\u00e9e ou forte. La recommandation est fond\u00e9e sur les r\u00e9sultats d\u2019un programme pilote en cours au Ghana, au Kenya et au Malawi […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Dafra Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-13T11:41:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-23T07:51:45+00:00\" \/>\n<meta name=\"author\" content=\"Yana Van Leynseele\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Yana Van Leynseele\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\\\/\"},\"author\":{\"name\":\"Yana Van Leynseele\",\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#\\\/schema\\\/person\\\/ca112ede12072ac81394430bf9157b03\"},\"headline\":\"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE – 6 octobre, 2021\",\"datePublished\":\"2021-10-13T11:41:15+00:00\",\"dateModified\":\"2021-11-23T07:51:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\\\/\"},\"wordCount\":132,\"publisher\":{\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#organization\"},\"articleSection\":[\"octobre 2021\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\\\/\",\"url\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\\\/\",\"name\":\"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE - 6 octobre, 2021 - Dafra Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#website\"},\"datePublished\":\"2021-10-13T11:41:15+00:00\",\"dateModified\":\"2021-11-23T07:51:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE – 6 octobre, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/\",\"name\":\"Dafra Pharma\",\"description\":\"our quality healthcare partner in Sub-Saharan Africa\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#organization\",\"name\":\"Dafra Pharma\",\"url\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.dafrapharma.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/Dafra-logo-01-1.svg\",\"contentUrl\":\"https:\\\/\\\/www.dafrapharma.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/Dafra-logo-01-1.svg\",\"caption\":\"Dafra Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/#\\\/schema\\\/person\\\/ca112ede12072ac81394430bf9157b03\",\"name\":\"Yana Van Leynseele\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfe00c59874f7136c7b3163cf7f050bbfd77c1c250da93fa8143598303807b95?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfe00c59874f7136c7b3163cf7f050bbfd77c1c250da93fa8143598303807b95?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfe00c59874f7136c7b3163cf7f050bbfd77c1c250da93fa8143598303807b95?s=96&d=mm&r=g\",\"caption\":\"Yana Van Leynseele\"},\"url\":\"https:\\\/\\\/www.dafrapharma.com\\\/fr\\\/author\\\/yana\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE - 6 octobre, 2021 - Dafra Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/","og_locale":"fr_FR","og_type":"article","og_title":"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE - 6 octobre, 2021 - Dafra Pharma","og_description":"L\u2019Organisation mondiale de la Sant\u00e9 (OMS) recommande l\u2019utilisation g\u00e9n\u00e9ralis\u00e9e du vaccin antipaludique RTS,S\/AS01 (RTS,S) chez les enfants en Afrique subsaharienne et dans d’autres r\u00e9gions o\u00f9 la transmission du paludisme \u00e0 P. falciparum est mod\u00e9r\u00e9e ou forte. La recommandation est fond\u00e9e sur les r\u00e9sultats d\u2019un programme pilote en cours au Ghana, au Kenya et au Malawi […]","og_url":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/","og_site_name":"Dafra Pharma","article_published_time":"2021-10-13T11:41:15+00:00","article_modified_time":"2021-11-23T07:51:45+00:00","author":"Yana Van Leynseele","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Yana Van Leynseele","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/#article","isPartOf":{"@id":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/"},"author":{"name":"Yana Van Leynseele","@id":"https:\/\/www.dafrapharma.com\/fr\/#\/schema\/person\/ca112ede12072ac81394430bf9157b03"},"headline":"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE – 6 octobre, 2021","datePublished":"2021-10-13T11:41:15+00:00","dateModified":"2021-11-23T07:51:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/"},"wordCount":132,"publisher":{"@id":"https:\/\/www.dafrapharma.com\/fr\/#organization"},"articleSection":["octobre 2021"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/","url":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/","name":"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE - 6 octobre, 2021 - Dafra Pharma","isPartOf":{"@id":"https:\/\/www.dafrapharma.com\/fr\/#website"},"datePublished":"2021-10-13T11:41:15+00:00","dateModified":"2021-11-23T07:51:45+00:00","breadcrumb":{"@id":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.dafrapharma.com\/fr\/vaccin-antipaludique-novateur-destine-aux-enfants-exposes-au-risque-de-contracter-la-maladie-6-octobre-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.dafrapharma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"VACCIN ANTIPALUDIQUE NOVATEUR DESTIN\u00c9 AUX ENFANTS EXPOS\u00c9S AU RISQUE DE CONTRACTER LA MALADIE – 6 octobre, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.dafrapharma.com\/fr\/#website","url":"https:\/\/www.dafrapharma.com\/fr\/","name":"Dafra Pharma","description":"our quality healthcare partner in Sub-Saharan Africa","publisher":{"@id":"https:\/\/www.dafrapharma.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dafrapharma.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.dafrapharma.com\/fr\/#organization","name":"Dafra Pharma","url":"https:\/\/www.dafrapharma.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.dafrapharma.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.dafrapharma.com\/wp-content\/uploads\/2021\/04\/Dafra-logo-01-1.svg","contentUrl":"https:\/\/www.dafrapharma.com\/wp-content\/uploads\/2021\/04\/Dafra-logo-01-1.svg","caption":"Dafra Pharma"},"image":{"@id":"https:\/\/www.dafrapharma.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.dafrapharma.com\/fr\/#\/schema\/person\/ca112ede12072ac81394430bf9157b03","name":"Yana Van Leynseele","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/bfe00c59874f7136c7b3163cf7f050bbfd77c1c250da93fa8143598303807b95?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bfe00c59874f7136c7b3163cf7f050bbfd77c1c250da93fa8143598303807b95?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfe00c59874f7136c7b3163cf7f050bbfd77c1c250da93fa8143598303807b95?s=96&d=mm&r=g","caption":"Yana Van Leynseele"},"url":"https:\/\/www.dafrapharma.com\/fr\/author\/yana\/"}]}},"_links":{"self":[{"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/posts\/5602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/comments?post=5602"}],"version-history":[{"count":0,"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/posts\/5602\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/media?parent=5602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/categories?post=5602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dafrapharma.com\/fr\/wp-json\/wp\/v2\/tags?post=5602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}